Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meir Wetzler

Showing results (51-60 of 120) with videos related to

Pageof 12
Sort By:
Leukemia Research Reports|May 3, 2017
Dexrazoxane for cardioprotection in older adults with acute myeloid leukemiaPankit Vachhani, Sarah Shin, Jeffrey Baron, et al.
American Journal of Hematology|March 27, 2015
Comparison of epigenetic versus standard induction chemotherapy for newly diagnosed acute myeloid leukemia patients ≥60 years oldNeha Gupta, Austin Miller, Shipra Gandhi, et al.
Journal of Clinical Psychology in Medical Settings|July 18, 2016
Adjustment to Acute Leukemia: The Impact of Social Support and Marital Satisfaction on Distress and Quality of Life Among Newly Diagnosed Patients and Their CaregiversMegan E Pailler, Teresa M Johnson, Sarah Kuszczak, et al.
Leukemia Research|February 3, 2009
Metachronous and synchronous presentation of acute myeloid leukemia and lung cancerRamya Varadarajan, LaurieAnn Ford, Sheila N J Sait, et al.
Cancer|July 1, 2011
Phase 2 randomized study of p53 antisense oligonucleotide (cenersen) plus idarubicin with or without cytarabine in refractory and relapsed acute myeloid leukemiaJorge Cortes, Hagop Kantarjian, Edward D Ball, et al.
Blood|February 1, 2007
Effective asparagine depletion with pegylated asparaginase results in improved outcomes in adult acute lymphoblastic leukemia: Cancer and Leukemia Group B Study 9511Meir Wetzler, Ben L Sanford, Joanne Kurtzberg, et al.
Cancer Chemotherapy and Pharmacology|July 13, 2005
Sequential administration of irinotecan and cytarabine in the treatment of relapsed and refractory acute myeloid leukemiaHans Minderman, Kieran L O'Loughlin, Patrick F Smith, et al.
British Journal of Haematology|January 14, 2004
Additional cytogenetic abnormalities in adults with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a study of the Cancer and Leukaemia Group BMeir Wetzler, Richard K Dodge, Krzysztof Mrózek, et al.
Leukemia & Lymphoma|May 3, 2008
Feasibility of administering oblimersen (G3139; Genasense) with imatinib mesylate in patients with imatinib resistant chronic myeloid leukemia--Cancer and leukemia group B study 10107Meir Wetzler, Kathleen A Donohue, Olatoyosi M Odenike, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 15, 2013
Phase I/II trial of nanomolecular liposomal annamycin in adult patients with relapsed/refractory acute lymphoblastic leukemiaMeir Wetzler, Debora A Thomas, Eunice S Wang, et al.
Pageof 12

Showing results (51-60 of 120) with videos related to

Sort By:
Pageof 12
Leukemia Research Reports|May 3, 2017
Dexrazoxane for cardioprotection in older adults with acute myeloid leukemiaPankit Vachhani, Sarah Shin, Jeffrey Baron, et al.
American Journal of Hematology|March 27, 2015
Comparison of epigenetic versus standard induction chemotherapy for newly diagnosed acute myeloid leukemia patients ≥60 years oldNeha Gupta, Austin Miller, Shipra Gandhi, et al.
Journal of Clinical Psychology in Medical Settings|July 18, 2016
Adjustment to Acute Leukemia: The Impact of Social Support and Marital Satisfaction on Distress and Quality of Life Among Newly Diagnosed Patients and Their CaregiversMegan E Pailler, Teresa M Johnson, Sarah Kuszczak, et al.
Leukemia Research|February 3, 2009
Metachronous and synchronous presentation of acute myeloid leukemia and lung cancerRamya Varadarajan, LaurieAnn Ford, Sheila N J Sait, et al.
Cancer|July 1, 2011
Phase 2 randomized study of p53 antisense oligonucleotide (cenersen) plus idarubicin with or without cytarabine in refractory and relapsed acute myeloid leukemiaJorge Cortes, Hagop Kantarjian, Edward D Ball, et al.
Blood|February 1, 2007
Effective asparagine depletion with pegylated asparaginase results in improved outcomes in adult acute lymphoblastic leukemia: Cancer and Leukemia Group B Study 9511Meir Wetzler, Ben L Sanford, Joanne Kurtzberg, et al.
Cancer Chemotherapy and Pharmacology|July 13, 2005
Sequential administration of irinotecan and cytarabine in the treatment of relapsed and refractory acute myeloid leukemiaHans Minderman, Kieran L O'Loughlin, Patrick F Smith, et al.
British Journal of Haematology|January 14, 2004
Additional cytogenetic abnormalities in adults with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a study of the Cancer and Leukaemia Group BMeir Wetzler, Richard K Dodge, Krzysztof Mrózek, et al.
Leukemia & Lymphoma|May 3, 2008
Feasibility of administering oblimersen (G3139; Genasense) with imatinib mesylate in patients with imatinib resistant chronic myeloid leukemia--Cancer and leukemia group B study 10107Meir Wetzler, Kathleen A Donohue, Olatoyosi M Odenike, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 15, 2013
Phase I/II trial of nanomolecular liposomal annamycin in adult patients with relapsed/refractory acute lymphoblastic leukemiaMeir Wetzler, Debora A Thomas, Eunice S Wang, et al.
Pageof 12